ScienceUKTNabout 2 hours ago
Neuronostics raises £3m to advance biomarker platform for epilepsy
2 min read
Bristol-based Neuronostics raised £3m to accelerate BioEP, a digital biomarker platform for epilepsy diagnosis and prognosis. BioEP analyzes background EEG activity using eight computational biomarkers to provide objective clinical decision support. People with suspected epilepsy wait over a year for diagnosis, with misdiagnosis rates exceeding 30%.
Level
Hype check
Tap to vote and see what everyone thinks.
